APA

Jurczak W., Moreira I., Kanakasetty G. B., Munhoz E., Echeveste M. A., Giri P., Castro N., Pereira J., Akria L., Alexeev S., Osmanov E., Zhu P., Alexandrova S., Zubel A., Harlin O. & Amersdorffer J. (20180312). Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study. : The Lancet. Haematology.

Chicago

Jurczak Wojciech, Moreira Ilídia, Kanakasetty Govind Babu, Munhoz Eduardo, Echeveste Maria Asunción, Giri Pratyush, Castro Nelson, Pereira Juliana, Akria Luiza, Alexeev Sergey, Osmanov Eugeniy, Zhu Peijuan, Alexandrova Siyka, Zubel Angela, Harlin Olof and Amersdorffer Jutta. 20180312. Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study. : The Lancet. Haematology.

Harvard

Jurczak W., Moreira I., Kanakasetty G. B., Munhoz E., Echeveste M. A., Giri P., Castro N., Pereira J., Akria L., Alexeev S., Osmanov E., Zhu P., Alexandrova S., Zubel A., Harlin O. and Amersdorffer J. (20180312). Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study. : The Lancet. Haematology.

MLA

Jurczak Wojciech, Moreira Ilídia, Kanakasetty Govind Babu, Munhoz Eduardo, Echeveste Maria Asunción, Giri Pratyush, Castro Nelson, Pereira Juliana, Akria Luiza, Alexeev Sergey, Osmanov Eugeniy, Zhu Peijuan, Alexandrova Siyka, Zubel Angela, Harlin Olof and Amersdorffer Jutta. Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study. : The Lancet. Haematology. 20180312.